Unlock the potential of biosimilars: Improve patient access and long-term healthcare sustainability
Evvnt Promotion / evvnt
Archivo
10.05.2021 Online, Germany
Time: 3:00 pm - 5:00 pm
Temas de la conferencia
Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare system sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.
Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare system sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.
Organizador profesional (PCO)
Reuters Events
Reuters Events
Información e inscripción:
Mr. Josh Bramwell
Medicina General
Idioma
Inglés
Inglés
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
